Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Eliquis
Pharma
Pfizer's COVID franchise keeps guidance level after strong Q1
Buoyed by notable sales beats from Eliquis, Prevnar and Ibrance, Pfizer’s revenue rose 2% year over year on an operational basis to $14.5 billion.
Fraiser Kansteiner
May 5, 2026 11:17am
BMS maintains Camzyos confidence amid Cytokinetics competition
Apr 30, 2026 2:20pm
BMS turns focus to new growth drivers as legacy meds decline
Feb 5, 2026 11:45am
BMS, Pfizer to provide discounted Eliquis through online program
Jul 17, 2025 10:59am
After $1.5B cost-cutting plan, BMS will cut an additional $2B
Feb 6, 2025 8:33am
BMS cuts 195 jobs, bringing head count reduction to 1,329 in NJ
Nov 25, 2024 12:59pm
